Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-related Lymphedema
Status: | Completed |
---|---|
Conditions: | Cancer, Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/22/2019 |
Start Date: | October 2016 |
End Date: | February 2018 |
Assessment of Lymphatic Structure and Function Pre- and Post- Treatment and During Recovery in Head and Neck Cancer Patients Using NIR Fluorescence Lymphatic Imaging
Assessment of lymphatic structure and function pre- and post- treatment and during recovery
in head and neck cancer related lymphedema patients using NIR fluorescence lymphatic imaging:
Response to ICD therapy in HNC Patients.
in head and neck cancer related lymphedema patients using NIR fluorescence lymphatic imaging:
Response to ICD therapy in HNC Patients.
A non-randomized, non-blinded, single site pilot study designed to assess whether
near-infrared fluorescence imaging can report on the efficacy of a pneumatic compression
device to move lymph in head and neck cancer survivors with resulting head and neck
lymphedema.
near-infrared fluorescence imaging can report on the efficacy of a pneumatic compression
device to move lymph in head and neck cancer survivors with resulting head and neck
lymphedema.
Inclusion Criteria:
- Participants must be 18 years of age or older
- Participants must be diagnosed with Lymphedema of the Head and/or Neck
- Participants must be diagnosed with squamous cell carcinoma of the oral cavity,
oropharynx or larynx and underwent surgery and radiation as part of their
standard-of-care treatment plan.
- Participants must be ≥ 4 weeks post-radiation therapy
- Female participants of childbearing potential must have a negative urine pregnancy
test ≤ 36 hours prior to study drug administration
- Female participants of childbearing potential must agree to use a medically accepted
method of contraception for a period of one month after each imaging session
- Participants must be willing to use the Flexitouch® System at home daily for two (2)
weeks
Exclusion Criteria:
- Women who are pregnant or breast-feeding
- Persons who are allergic to iodine
- A female of child-bearing potential, who does not agree to use an approved
contraceptive for one month after study participation
- Persons who do not meet inclusion criteria
- Persons with pulmonary edema, thrombophlebitis, congestive heart failure, deep vein
thrombosis, episodes of pulmonary embolism, infections and inflammation, or acute
cancer
- Persons with uncontrolled hyperthyroidism or parathyroidism (for with an
endocrinologist recommends against neck compression)
- Carotid sinus hypersensitivity syndrome
- Symptomatic carotid artery disease, as manifested by a recent transient ischemic
attack (within 30 days), ischemic stroke, or amaurosis fugax (monocular visual
ischemic symptoms or blindness)
- Symptomatic bradycardia in the absence of a pacemaker
- Internal jugular venous thrombosis, acute or within 3 months
- Known intracranial pressure or other contraindication to internal or external jugular
venous compression
- Acute radiation dermatitis, unhealed surgical scar, unhealed or open wound(s),
surgical flap less than 6-8 weeks post-operative
- Facial or head and neck dermal metastasis
- Acute facial infection (e.g., facial or parotid gland abscess)
- Any condition where increased venous and lymphatic return is undesirable
We found this trial at
1
site
Houston, Texas 77030
Principal Investigator: Eva Sevick, PhD
Phone: 713-500-3562
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)